AstraZeneca Profit Margin 2006-2018 | AZN

Current and historical gross margin, operating margin and net profit margin for AstraZeneca (AZN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. AstraZeneca net profit margin as of June 30, 2018 is 11.98%.
AstraZeneca Annual Profit Margins
AstraZeneca Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $99.517B $22.465B
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $374.158B 17.54
Pfizer (PFE) United States $265.319B 15.53
Novartis AG (NVS) Switzerland $197.633B 16.95
Merck (MRK) United States $193.640B 17.10
AbbVie (ABBV) United States $139.722B 13.65
Eli Lilly (LLY) United States $121.994B 22.58
Sanofi (SNY) France $112.061B 14.18
Novo Nordisk (NVO) Denmark $106.293B 16.99
GlaxoSmithKline (GSK) United Kingdom $98.553B 13.16
Bristol-Myers Squibb (BMY) United States $96.274B 17.43